Loading...
Redcare Pharmacy NV
RDC.DE•XETRA
HealthcareMedical - Pharmaceuticals
€100.20
€1.65(1.67%)
Redcare Pharmacy NV (RDC.DE) Financial Performance & Statements
Review Redcare Pharmacy NV’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
31.79%
↑ 31.79%
Operating Income Growth
-125.42%
↓ 125.42%
Net Income Growth
-277.58%
↓ 277.58%
Operating Cash Flow Growth
-64.00%
↓ 64.00%
Operating Margin
-1.65%
↓ 1.65%
Gross Margin
21.61%
↑ 21.61%
Net Profit Margin
-1.92%
↓ 1.92%
ROE
-9.16%
↓ 9.16%
ROIC
-5.20%
↓ 5.20%
Redcare Pharmacy NV (RDC.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Redcare Pharmacy NV stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $675.14M | $574.55M | $560.67M | $560.22M |
| Cost of Revenue | $524.68M | $441.23M | $446.62M | $445.65M |
| Gross Profit | $150.45M | $133.31M | $114.06M | $114.56M |
| Gross Profit Ratio | $0.22 | $0.23 | $0.20 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $170.44M | $140.17M | $117.25M | $120.32M |
| Operating Expenses | $174.06M | $123.07M | $117.25M | $120.32M |
| Total Costs & Expenses | $698.75M | $581.20M | $563.87M | $565.97M |
| Interest Income | $371000.00 | $3.03M | $1.66M | $1.34M |
| Interest Expense | $4.03M | $4.05M | $3.81M | $4.25M |
| Depreciation & Amortization | $5.53M | $17.10M | $17.08M | $16.32M |
| EBITDA | -$14.55M | $13.47M | $15.71M | $11.97M |
| EBITDA Ratio | -$0.02 | $0.02 | $0.03 | $0.02 |
| Operating Income | -$23.61M | -$6.66M | -$3.19M | -$5.76M |
| Operating Income Ratio | -$0.03 | -$0.01 | -$0.006 | -$0.01 |
| Other Income/Expenses (Net) | -$2.88M | -$899000.00 | -$2.15M | -$2.91M |
| Income Before Tax | -$26.50M | -$7.55M | -$5.18M | -$8.60M |
| Income Before Tax Ratio | -$0.04 | -$0.01 | -$0.009 | -$0.02 |
| Income Tax Expense | -$218000.00 | -$448000.00 | -$396000.00 | -$415000.00 |
| Net Income | -$26.48M | -$6.91M | -$4.27M | -$7.80M |
| Net Income Ratio | -$0.04 | -$0.01 | -$0.008 | -$0.01 |
| EPS | -$1.30 | -$0.35 | -$0.21 | -$0.39 |
| Diluted EPS | -$1.30 | -$0.35 | -$0.21 | -$0.39 |
| Weighted Avg Shares Outstanding | $20.11M | $20.02M | $19.89M | $20.02M |
| Weighted Avg Shares Outstanding (Diluted) | $20.11M | $20.02M | $19.89M | $20.02M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan